Xthetix
Founded Year
2006Stage
Series A | AliveTotal Raised
$2MLast Raised
$2M | 17 yrs agoAbout Xthetix
HomeContact Us Efficacious skin care devices for consumersXthetix, Inc. is a consumer skin care medical device companyIntent to become a provider in home based medical aesthetic devicesintense ultrasound (IUS) technology adopted from GTS (Guided Therapy Systems) technologyXthetix is offering a portfolio of products addressing three large and growing segments:
Xthetix Frequently Asked Questions (FAQ)
When was Xthetix founded?
Xthetix was founded in 2006.
Where is Xthetix's headquarters?
Xthetix's headquarters is located at 33 South Sycamore Street, Mesa.
What is Xthetix's latest funding round?
Xthetix's latest funding round is Series A.
How much did Xthetix raise?
Xthetix raised a total of $2M.
Who are the investors of Xthetix?
Investors of Xthetix include 3i Group.
Who are Xthetix's competitors?
Competitors of Xthetix include Keystone Dental, CivaTech Oncology, Natus Medical, Optovue, Ultrasound Medical Devices and 10 more.
Compare Xthetix to Competitors

Smart Animal is a medical devices company developing prototypes to enable patient-specific imaging and targeted therapy.
Adnavance Technologies Inc is developing enabling technology applications that use the conductivity properties of both normal and novel metallic forms of DNA aimed at large biosensormolecular diagnostics and energy generationmanagement markets
InPhenix is a developer and manufacturer of optoelectronic devices for the medical, defense, and telecom markets. The company's Super Light Emitting Diodes (SLEDs) are utilized in a variety of optical imaging systems for biomedical applications, and its customers include several leading manufacturers of ophthalmic and laboratory diagnostic instrumentation.
Emergent Respiratory Products, Inc., located in Irvine, CA, aims to develop, manufacture and market a medical device for delivering non-invasive ventilation therapy. Emergent's products can be utilized in a range of care settings, including emergency medical service (EMS) transport to the hospital and alternative site/home care settings.
Molnlycke Health Care is a manufacturer of single-use surgical and wound care products. The company's products help patients feel less pain and aid healthcare professionals to safer and more efficient surgery.
Insense Ltd has developed and patented a technology platform centred on the feature of in-situ wound oxygenation. Its first products, Oxyzyme and Iodozyme, target chronic wounds and will be launched into the professional healthcare market.